---
kind: "section"
citation: "42 U.S.C. § 300cc–20"
title: "42"
title_heading: "The Public Health and Welfare"
number: "300cc–20"
heading: "Additional authority with respect to research"
release: "119-102"
date: "2026-07-12"
url: "https://uscodex.org/usc/42/300cc-20"
units:
  - "Chapter 6A — Public Health Service"
  - "Subchapter XXI — Research with Respect to Acquired Immune Deficiency Syndrome"
  - "Part B — Research Authority"
---

# §300cc–20. Additional authority with respect to research

- (a) **Data collection with respect to national prevalence—**
  - (1) The [Secretary](/usc/42/201.md?p=c), acting through the [Director](/usc/42/11851.md?p=5) of the Centers for Disease Control and Prevention, may, through representative sampling and other appropriate methodologies, provide for the continuous collection of data on the incidence in the United States of cases of acquired immune deficiency syndrome and of cases of infection with the etiologic agent for such syndrome. The [Secretary](/usc/42/201.md?p=c) may carry out the [program](/usc/42/274l–1.md?p=4) of data collection directly or through cooperative agreements and contracts with public and [nonprofit](/usc/42/300s–3.md?p=3) private entities.
  - (2) The [Secretary](/usc/42/201.md?p=c) shall encourage each [State](/usc/42/201.md?p=f) to enter into a cooperative agreement or contract under [paragraph (1)](#a-1) with the [Secretary](/usc/42/201.md?p=c) in order to facilitate the prompt collection of the most recent accurate data on the incidence of cases described in such paragraph.
  - (3) The [Secretary](/usc/42/201.md?p=c) shall ensure that data collected under [paragraph (1)](#a-1) includes data on the demographic characteristics of the population of individuals with cases described in [paragraph (1)](#a-1), including data on specific subpopulations at risk of infection with the etiologic agent for acquired immune deficiency syndrome.
  - (4) In carrying out this subsection, the [Secretary](/usc/42/201.md?p=c) shall, for the purpose of assuring the utility of data collected under this section, request entities with expertise in the methodologies of data collection to provide, as soon as is practicable, assistance to the [Secretary](/usc/42/201.md?p=c) and to the [States](/usc/42/201.md?p=f) with respect to the development and utilization of uniform methodologies of data collection.
  - (5) The [Secretary](/usc/42/201.md?p=c) shall provide for the dissemination of data collected pursuant to this subsection. In carrying out this paragraph, the [Secretary](/usc/42/201.md?p=c) may publish such data as frequently as the [Secretary](/usc/42/201.md?p=c) determines to be appropriate with respect to the protection of the public health. The [Secretary](/usc/42/201.md?p=c) shall publish such data not less than once each year.
- (b) **Epidemiological and demographic data—**
  - (1) The [Secretary](/usc/42/201.md?p=c), acting through the [Director](/usc/42/11851.md?p=5) of the Centers for Disease Control and Prevention, shall develop an epidemiological data base and shall provide for long-term studies for the purposes of—
    - (A) collecting information on the demographic characteristics of the population of individuals infected with the etiologic agent for acquired immune deficiency syndrome and the natural history of such infection; and
    - (B) developing models demonstrating the long-term domestic and international patterns of the transmission of such etiologic agent.
  - (2) The [Secretary](/usc/42/201.md?p=c) may carry out [paragraph (1)](#b-1) directly or through grants to, or cooperative agreeements[^1] or contracts with, public and [nonprofit](/usc/42/300s–3.md?p=3) private entities, including Federal [agencies](/usc/42/8262.md?p=1).
- (c) **Long-term research—** The [Secretary](/usc/42/201.md?p=c) may make grants to public and [nonprofit](/usc/42/300s–3.md?p=3) private entities for the purpose of assisting grantees in conducting long-term research into [treatments](/usc/42/11851.md?p=11) for acquired immune deficiency syndrome developed from knowledge of the genetic nature of the etiologic agent for such syndrome.
- (d) **Social sciences research—** The [Secretary](/usc/42/201.md?p=c), acting through the [Director](/usc/42/11851.md?p=5) of the National Institute of Mental Health, may make grants to public and [nonprofit](/usc/42/300s–3.md?p=3) private entities for the purpose of assisting grantees in conducting scientific research into the psychological and social sciences as such sciences relate to acquired immune deficiency syndrome.
- (e) **Authorization of appropriations—**
  - (1) For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each fiscal year.
  - (2) Amounts appropriated pursuant to [paragraph (1)](#e-1) to carry out [subsection (c)](#c) shall remain available until expended.

## Footnotes

[^1]: So in original.

## Source credit

(July 1, 1944, ch. 373, title XXIII, § 2320, as added Pub. L. 100–607, title II, § 201(4), Nov. 4, 1988, 102 Stat. 3074; amended Pub. L. 100–690, title II, § 2617(d), Nov. 18, 1988, 102 Stat. 4240; Pub. L. 102–531, title III, § 312(d)(20), Oct. 27, 1992, 106 Stat. 3505; Pub. L. 103–43, title XVIII, § 1811(5), (6), June 10, 1993, 107 Stat. 200.)

## Notes

### Editorial Notes

### Amendments

1993—Subsec. (b)(1)(A). Pub. L. 103–43, § 1811(5), inserted “and the natural history of such infection” after “syndrome”.

Subsec. (e)(1). Pub. L. 103–43, § 1811(6), substituted “fiscal year” for “of the fiscal years 1989 through 1991”.

1992—Subsecs. (a)(1), (b)(1). Pub. L. 102–531 substituted “Centers for Disease Control and Prevention” for “Centers for Disease Control”.

1988—Subsec. (a)(5). Pub. L. 100–690 substituted “subsection” for “section”.

### Statutory Notes and Related Subsidiaries

### Effective Date of 1988 Amendment

Amendment by Pub. L. 100–690 effective immediately after enactment of Pub. L. 100–607, which was approved Nov. 4, 1988, see section 2600 of Pub. L. 100–690, set out as a note under section 242m of this title.